Literature DB >> 26014515

Risk factors and prediction-score model for distant metastasis in nasopharyngeal carcinoma treated with intensity-modulated radiotherapy.

An-Chuan Li1,2, Wei-Wei Xiao1, Lin Wang1, Guan-Zhu Shen1, An-An Xu1,3, Yan-Qing Cao1,4, Shao-Min Huang1, Cheng-Guang Lin1, Fei Han1, Xiao-Wu Deng1, Chong Zhao5.   

Abstract

The objective of this study is to identify the risk factors and construct a prediction-score model for distant metastasis (DM) in nasopharyngeal carcinoma (NPC) patients treated with intensity-modulated radiotherapy (IMRT). A total of 520 nonmetastatic NPC patients were analysed retrospectively. The independent risk factors for DM were tested by multivariate Cox regression analysis. The prediction-score model was established according to the regression coefficient. The median follow-up was 88.4 months. The 5-year DM rate was 15.1%. N2-3, primary tumour volume of nasopharynx (GTVnx) >24.56 cm(3), haemoglobin change after treatment (ΔHGB) >25.8 g/L, albumin-globulin ratio (AGR) ≤1.34, pretreatment neutrophil-lymphocyte ratio (NLR) >2.81 and pretreatment serum lactate dehydrogenase (LDH) >245 U/L were significantly adverse independent predictive factors for DM. Three subgroups were defined based on the prediction-score model: low risk (0-2), intermediate risk (3-4) and high risk (5-8). The 5-year DM rates were 4.6, 21.8 and 50.8%, respectively (P < 0.001). The areas under the curve for DM in the prediction-score model and the UICC/AJCC staging system seventh edition were 0.748 and 0.627, respectively (P < 0.001). The scoring model is useful in evaluating the risk of DM in IMRT-treated NPC patients and guiding future therapeutic trials. Further prospective study is needed.

Entities:  

Keywords:  Distant metastasis; Intensity-modulated radiotherapy; Nasopharyngeal carcinoma; Prediction-score model

Mesh:

Year:  2015        PMID: 26014515     DOI: 10.1007/s13277-015-3574-0

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  45 in total

1.  Clinical outcomes and patterns of failure after intensity-modulated radiotherapy for nasopharyngeal carcinoma.

Authors:  Wai Tong Ng; Michael C H Lee; Wai Man Hung; Cheuk Wai Choi; Kin Chung Lee; Oscar S H Chan; Anne W M Lee
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-05-06       Impact factor: 7.038

2.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

Review 3.  Host-tumor interactions in nasopharyngeal carcinomas.

Authors:  Claire Gourzones; Clément Barjon; Pierre Busson
Journal:  Semin Cancer Biol       Date:  2012-01-11       Impact factor: 15.707

4.  To build a prognostic score model containing indispensible tumour markers for metastatic nasopharyngeal carcinoma in an epidemic area.

Authors:  Y Jin; X Y Cai; Y C Cai; Y Cao; Q Xia; Y T Tan; W Q Jiang; Y X Shi
Journal:  Eur J Cancer       Date:  2011-10-24       Impact factor: 9.162

Review 5.  Treatment for metastatic nasopharyngeal carcinoma.

Authors:  Y Bensouda; W Kaikani; N Ahbeddou; R Rahhali; M Jabri; H Mrabti; H Boussen; H Errihani
Journal:  Eur Ann Otorhinolaryngol Head Neck Dis       Date:  2010-12-21       Impact factor: 2.080

6.  Tumor heterogeneity, tumor size, and radioresistance.

Authors:  R J Yaes
Journal:  Int J Radiat Oncol Biol Phys       Date:  1989-11       Impact factor: 7.038

7.  Clinical application of tumor volume in advanced nasopharyngeal carcinoma to predict outcome.

Authors:  Ching-Chih Lee; Tze-Ta Huang; Moon-Sing Lee; Shih-Hsuan Hsiao; Hon-Yi Lin; Yu-Chieh Su; Feng-Chun Hsu; Shih-Kai Hung
Journal:  Radiat Oncol       Date:  2010-03-11       Impact factor: 3.481

8.  Oxygen tension distributions are sufficient to explain the local response of human breast tumors treated with radiation alone.

Authors:  P Okunieff; M Hoeckel; E P Dunphy; K Schlenger; C Knoop; P Vaupel
Journal:  Int J Radiat Oncol Biol Phys       Date:  1993-07-15       Impact factor: 7.038

9.  The hazard of accelerated tumor clonogen repopulation during radiotherapy.

Authors:  H R Withers; J M Taylor; B Maciejewski
Journal:  Acta Oncol       Date:  1988       Impact factor: 4.089

10.  Clinical outcomes and prognostic factors of 695 nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy.

Authors:  Weidong Wang; Mei Feng; Zixuan Fan; Jie Li; Jinyi Lang
Journal:  Biomed Res Int       Date:  2014-08-05       Impact factor: 3.411

View more
  14 in total

1.  Pretreatment neutrophil to lymphocyte ratio in determining the prognosis of head and neck cancer: a meta-analysis.

Authors:  Yalian Yu; Hongbo Wang; Aihui Yan; Hailong Wang; Xinyao Li; Jiangtao Liu; Wei Li
Journal:  BMC Cancer       Date:  2018-04-04       Impact factor: 4.430

Review 2.  Prognostic significance of pretreated serum lactate dehydrogenase level in nasopharyngeal carcinoma among Chinese population: A meta-analysis.

Authors:  Mingwei Zhang; Shushan Wei; Li Su; Wenlong Lv; Jinsheng Hong
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

3.  Prognostic implications of dynamic serum lactate dehydrogenase assessments in nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy.

Authors:  Guan-Qun Zhou; Xian-Yue Ren; Yan-Ping Mao; Lei Chen; Ying Sun; Li-Zhi Liu; Li Li; Ai-Hua Lin; Hai-Qiang Mai; Jun Ma
Journal:  Sci Rep       Date:  2016-03-01       Impact factor: 4.379

4.  Pretreatment Serum Lactate Dehydrogenase Level as an Independent Prognostic Factor of Nasopharyngeal Carcinoma in the Intensity-Modulated Radiation Therapy Era.

Authors:  Zhuhong Chen; Qiaojuan Guo; Tianzhu Lu; Shaojun Lin; Jingfeng Zong; Shenghua Zhan; Luying Xu; Jianji Pan
Journal:  Med Sci Monit       Date:  2017-01-25

5.  Prognostic values of the integrated model incorporating the volume of metastatic regional cervical lymph node and pretreatment serum Epstein-Barr virus DNA copy number in predicting distant metastasis in patients with N1 nasopharyngeal carcinoma.

Authors:  Ji-Jin Yao; Guan-Qun Zhou; Ya-Qin Wang; Si-Yang Wang; Wang-Jian Zhang; Ya-Nan Jin; Fan Zhang; Li Li; Li-Zhi Liu; Zhi-Bin Cheng; Jun Ma; Zhen-Yu Qi; Ying Sun
Journal:  Chin J Cancer       Date:  2017-12-29

6.  Prognostic Effect of Albumin-to-Globulin Ratio in Patients with solid tumors: A Systematic Review and Meta-analysis.

Authors:  Jiaxi He; Hui Pan; Wenhua Liang; Dakai Xiao; Xuewei Chen; Minzhang Guo; Jianxing He
Journal:  J Cancer       Date:  2017-10-23       Impact factor: 4.207

7.  Identifying pretreatment baseline factors predictive of distant metastasis in patients with nasopharyngeal carcinoma after radiotherapy.

Authors:  Yu Wang; Guojian Chen
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

8.  JMJD2A promotes the Warburg effect and nasopharyngeal carcinoma progression by transactivating LDHA expression.

Authors:  Yi Su; Qiu-Hong Yu; Xiang-Yun Wang; Li-Ping Yu; Zong-Feng Wang; Ying-Chun Cao; Jian-Dong Li
Journal:  BMC Cancer       Date:  2017-07-11       Impact factor: 4.430

9.  Long non-coding RNA CRYBG3 regulates glycolysis of lung cancer cells by interacting with lactate dehydrogenase A.

Authors:  Huaiyuan Chen; Hailong Pei; Wentao Hu; Ji Ma; Jian Zhang; Weidong Mao; Jing Nie; Chao Xu; Bingyan Li; Tom K Hei; Chang Wang; Guangming Zhou
Journal:  J Cancer       Date:  2018-06-23       Impact factor: 4.207

10.  Prognostic Evaluation of Nasopharyngeal Carcinoma with Bone-Only Metastasis after Therapy.

Authors:  Tianzhu Lu; Qiaojuan Guo; Xiaofei Cui; Zhuhong Chen; Shaojun Lin; Luying Xu; Jin Lin; Jingfeng Zong; Jianji Pan
Journal:  Yonsei Med J       Date:  2016-07       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.